Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukemia

被引：0
|
作者：
机构：
[1] Yang, Li-Hua
[2] Lu, Xin-Tian
[3] Lu, Wei
[4] Wu, Ke-Hua
[5] Hua, Ying
[6] Zhao, Wei-Hong
来源：
Yang, L.-H. (yang_lihua@sina.com) | 2005年 / Chinese Medical Association卷 / 40期
关键词：
Drug products;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients
    Rahmayanti, Siti Utami
    Amalia, Riezki
    Rusdiana, Taofik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 141 - 155
  • [22] Hepatoxicity in a Patient with Acute Lymphoblastic Leukemia Receiving High-Dose Methotrexate
    Kalakota, Neeharika
    Sharma, Ashish
    Bhakta, Dimpal
    Gould, Milena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1346 - S1346
  • [23] Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
    EL-Khodary, Noha M.
    EL-Haggar, Sahar M.
    Eid, Manal A.
    Ebeid, Emad N.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 2053 - 2062
  • [24] The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group
    Ryan J. Beechinor
    Patrick A. Thompson
    Michael F. Hwang
    Ryan C. Vargo
    Lisa R. Bomgaars
    Jacqueline G. Gerhart
    ZoAnn E. Dreyer
    Daniel Gonzalez
    Clinical Pharmacokinetics, 2019, 58 : 899 - 910
  • [25] The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group
    Beechinor, Ryan J.
    Thompson, Patrick A.
    Hwang, Michael F.
    Vargo, Ryan C.
    Bomgaars, Lisa R.
    Gerhart, Jacqueline G.
    Dreyer, ZoAnn E.
    Gonzalez, Daniel
    CLINICAL PHARMACOKINETICS, 2019, 58 (07) : 899 - 910
  • [26] Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
    Noha M. EL-Khodary
    Sahar M. EL-Haggar
    Manal A. Eid
    Emad N. Ebeid
    Medical Oncology, 2012, 29 : 2053 - 2062
  • [27] Medium and high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia (ALL)
    Hedavatiasl, Amirabas
    Darbandi, Bahram
    Vossough, Parvaneh
    Faranoush, Mohammad
    Golpayegani, Mohammad Reza
    Zangooie, Rokhsaneh
    Yazdi, Fatemeh
    Rafsanjani, Khadijeh Arjmandi
    Ansari, Shahla
    Zarrabi, Mohammad
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 490 - 491
  • [28] Assessment of Renal Function During High-Dose Methotrexate Treatment in Children With Acute Lymphoblastic Leukemia
    Ylinen, Elisa
    Jahnukainen, Kirsi
    Saarinen-Pihkala, Ulla M.
    Jahnukainen, Timo
    PEDIATRIC BLOOD & CANCER, 2014, 61 (12) : 2199 - 2202
  • [29] Population pharmacokinetics of methotrexate in Egyptian children with lymphoblastic leukemia
    El Desoky, E. S.
    Ghazally, M. H.
    Singh, R. P.
    Abdelhamid, O. N.
    Derendorf, H.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 548 - 548
  • [30] Toxicity associated with high dose methotrexate in children with acute lymphoblastic leukemia
    Sinha, Rupal
    Bansal, Shweta
    Abedin, Sarfraz
    Kapoor, Gauri
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 526 - 526
12345